Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220684825> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W4220684825 endingPage "100316" @default.
- W4220684825 startingPage "100316" @default.
- W4220684825 abstract "Durvalumab 10 mg/kg every 2 weeks for 1 year after chemoradiation has improved overall survival (OS) in unresectable stage III NSCLC. Subsequently, a 20 mg/kg 4-weekly regimen was approved. The study goal was to compare the efficacy and toxicity of the two regimens.All patients with NSCLC treated with curative-intent chemoradiation followed by durvalumab from March 1, 2018 to December 31, 2020 at BC Cancer, British Columbia, Canada were included in this retrospective review. Durvalumab dosing schedule, toxicity, progression, and OS were collected. Comparisons between treatment groups were made using chi-square and independent t tests. Kaplan-Meier curves and log-rank test were used to analyze OS.A total of 152 patients were included in the 2-weekly group and 53 patients in the 4-weekly group. The median follow-up was 19.7 months and 12.0 months, respectively. The median OS was not reached, but 12-month survival rates were 88.4% versus 85.2% (p = 0.55). Toxicity profiles were similar in terms of sites and severity.There was no significant difference in efficacy or toxicity between the 2-weekly and 4-weekly durvalumab in this cohort of patients with advanced NSCLC previously treated with curative-intent chemoradiation." @default.
- W4220684825 created "2022-04-03" @default.
- W4220684825 creator A5006058902 @default.
- W4220684825 creator A5011715907 @default.
- W4220684825 creator A5012511065 @default.
- W4220684825 creator A5018106732 @default.
- W4220684825 creator A5026937640 @default.
- W4220684825 creator A5028137497 @default.
- W4220684825 creator A5037115517 @default.
- W4220684825 creator A5041084323 @default.
- W4220684825 creator A5061600787 @default.
- W4220684825 creator A5087116862 @default.
- W4220684825 creator A5088331751 @default.
- W4220684825 date "2022-05-01" @default.
- W4220684825 modified "2023-10-12" @default.
- W4220684825 title "Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report" @default.
- W4220684825 cites W2228221433 @default.
- W4220684825 cites W2560704457 @default.
- W4220684825 cites W2753065806 @default.
- W4220684825 cites W2977392388 @default.
- W4220684825 cites W3108819942 @default.
- W4220684825 cites W4226175083 @default.
- W4220684825 doi "https://doi.org/10.1016/j.jtocrr.2022.100316" @default.
- W4220684825 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35498385" @default.
- W4220684825 hasPublicationYear "2022" @default.
- W4220684825 type Work @default.
- W4220684825 citedByCount "3" @default.
- W4220684825 countsByYear W42206848252023 @default.
- W4220684825 crossrefType "journal-article" @default.
- W4220684825 hasAuthorship W4220684825A5006058902 @default.
- W4220684825 hasAuthorship W4220684825A5011715907 @default.
- W4220684825 hasAuthorship W4220684825A5012511065 @default.
- W4220684825 hasAuthorship W4220684825A5018106732 @default.
- W4220684825 hasAuthorship W4220684825A5026937640 @default.
- W4220684825 hasAuthorship W4220684825A5028137497 @default.
- W4220684825 hasAuthorship W4220684825A5037115517 @default.
- W4220684825 hasAuthorship W4220684825A5041084323 @default.
- W4220684825 hasAuthorship W4220684825A5061600787 @default.
- W4220684825 hasAuthorship W4220684825A5087116862 @default.
- W4220684825 hasAuthorship W4220684825A5088331751 @default.
- W4220684825 hasBestOaLocation W42206848251 @default.
- W4220684825 hasConcept C121608353 @default.
- W4220684825 hasConcept C126322002 @default.
- W4220684825 hasConcept C141071460 @default.
- W4220684825 hasConcept C2776694085 @default.
- W4220684825 hasConcept C2777701055 @default.
- W4220684825 hasConcept C2777742743 @default.
- W4220684825 hasConcept C2778239845 @default.
- W4220684825 hasConcept C2778424827 @default.
- W4220684825 hasConcept C2780030458 @default.
- W4220684825 hasConcept C2781413609 @default.
- W4220684825 hasConcept C29730261 @default.
- W4220684825 hasConcept C3019894029 @default.
- W4220684825 hasConcept C50382708 @default.
- W4220684825 hasConcept C66339696 @default.
- W4220684825 hasConcept C71924100 @default.
- W4220684825 hasConcept C72563966 @default.
- W4220684825 hasConceptScore W4220684825C121608353 @default.
- W4220684825 hasConceptScore W4220684825C126322002 @default.
- W4220684825 hasConceptScore W4220684825C141071460 @default.
- W4220684825 hasConceptScore W4220684825C2776694085 @default.
- W4220684825 hasConceptScore W4220684825C2777701055 @default.
- W4220684825 hasConceptScore W4220684825C2777742743 @default.
- W4220684825 hasConceptScore W4220684825C2778239845 @default.
- W4220684825 hasConceptScore W4220684825C2778424827 @default.
- W4220684825 hasConceptScore W4220684825C2780030458 @default.
- W4220684825 hasConceptScore W4220684825C2781413609 @default.
- W4220684825 hasConceptScore W4220684825C29730261 @default.
- W4220684825 hasConceptScore W4220684825C3019894029 @default.
- W4220684825 hasConceptScore W4220684825C50382708 @default.
- W4220684825 hasConceptScore W4220684825C66339696 @default.
- W4220684825 hasConceptScore W4220684825C71924100 @default.
- W4220684825 hasConceptScore W4220684825C72563966 @default.
- W4220684825 hasIssue "5" @default.
- W4220684825 hasLocation W42206848251 @default.
- W4220684825 hasLocation W42206848252 @default.
- W4220684825 hasLocation W42206848253 @default.
- W4220684825 hasOpenAccess W4220684825 @default.
- W4220684825 hasPrimaryLocation W42206848251 @default.
- W4220684825 hasRelatedWork W151172257 @default.
- W4220684825 hasRelatedWork W2374795505 @default.
- W4220684825 hasRelatedWork W2418663701 @default.
- W4220684825 hasRelatedWork W2566535087 @default.
- W4220684825 hasRelatedWork W3128314482 @default.
- W4220684825 hasRelatedWork W3207294519 @default.
- W4220684825 hasRelatedWork W4200402535 @default.
- W4220684825 hasRelatedWork W4205334046 @default.
- W4220684825 hasRelatedWork W4283830178 @default.
- W4220684825 hasRelatedWork W4366351644 @default.
- W4220684825 hasVolume "3" @default.
- W4220684825 isParatext "false" @default.
- W4220684825 isRetracted "false" @default.
- W4220684825 workType "article" @default.